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Abstract
The transport activity of ceftibuten, a dianionic peptide-like compound, was extracted from rat intestinal brush-border
membrane by n-octylglucoside and reconstituted into asolectin liposomes by dialysis. The proteoliposomes prepared from
the membrane extract showed an inward Hq-gradient-dependent uptake of ceftibuten and glycylsarcosine. Ceftibuten-im-
mobilized affinity chromatography of the membrane extract permitted the isolation of two polypeptides apparent molecular
.mass of 117 and 127 kDa that can recognize the dianionic peptide structure of ceftibuten. Proteoliposomes prepared from
reconstituting the isolated proteins into asolectin vesicles showed an overshooting uptake of ceftibuten in the presence of an
inwardly directed Hq gradient, and this uptake could be inhibited by L-valyl-L-proline. N-glycanase digestion of the isolated
proteins, 117 and 127 kDa, trimmed them into 78 and 120 kDa products, respectively. The protein core size of the smaller
protein was in agreement with the calculated molecular mass of ;79 kDa for the rat PepT1 transporter obtained by other
investigators. q 1998 Elsevier Science B.V.
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1. Introduction
Oligopeptide transporters, which occupy a promis-
ing rank for pharmaceutical purposes, are specific for
 .di-, and tri-peptide but not amino acids and
peptide-like compounds such as b-lactam antibiotics,
angiotensin-converting enzyme inhibitors, renin in-
w xhibitors and bestatin 1–4 . From a physiological
viewpoint, the renal and small intestinal peptide
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transport systems play a vital role in the maintenance
of nitrogen balance and protein nutrition, whereas
from a pharmacological viewpoint, the low speci-
ficity and the ability of these transporters to interact
with a large number of structures are attractive fea-
tures that help in the rational design of pep-
tidomimetic drugs with improved pharmacodynamic
properties.
The use of various techniques such as isolated
w x w xmembrane vesicles 5,6 and intestinal cell culture 7
have contributed greatly to the characterization of the
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0005-2736 97 00258-7
( )K. Iseki et al.rBiochimica et Biophysica Acta 1370 1998 161–168162
oligopeptide transport system in the intestinal epithe-
lia. Recently, a cDNA encoding an oligopeptide
 . w xtransporter PepT1 was isolated from the rat 8 ,
w x w xrabbit 9 and human 10 small intestines, and the
transport characteristics were assessed by gene-ex-
pression systems. Yet it is considered that the physi-
cal isolation of the carrier proteins is a prerequisite
for a complete molecular description of the function
of these transport systems. Since the main problem
associated with the functional isolation of the carrier
proteins stems from the instability of these proteins
toward harsh conditions during the processing for
purification, the determination of the proper condi-
tions for the extraction and reconstitution into an
environment approximating the native membrane is
an integral and important part of the strategy for
w xpurification. Our previous papers, 11,12 , described
the proper conditions for the solubilization, purifica-
 .tion and functional reconstitution of the system s
responsible for the transport of ceftibuten, a peptide-
like compound, in rat renal brush-border membrane.
For the small intestine, however, only one method
with a lengthy protocol was reported by Kramer et al.
w x13 for the purification of rabbit small intestinal
oligopeptide transporter.
The purpose of the present study is to establish a
protocol for the purification and the functional recon-
 .stitution of the oligopeptide carrier protein s from rat
small intestine using affinity chromatography with
the immobilized substrate, ceftibuten. As described in
w xour previous studies 11,12 , ceftibuten, a water-solu-
ble dianionic cephem antibiotic, was used as a model
substrate. The availability of a high performance
 .liquid chromatography HPLC method for detecting
ceftibuten at a relatively high level of sensitivity
 .;5 pmol , the ability of this compound to interact
w xspecifically with the peptide transporter 14,15 and
the stability in aqueous media or against hydrolyzing
 .enzymes peptidase and b-lactamase , altogether,
were reasons for the selection of ceftibuten as a
model substrate.
2. Materials and methods
2.1. Materials
Ceftibuten and compound V, a 3-vinyl derivative,
 .were kindly donated by Shionogi Osaka, Japan .
 .n-octylglucoside n-octyl-b-D-glucoside was pur-
 .chased from Dojindo Kumamoto, Japan . Asolectin
 .L-a-lecithin, commercial grade type II-S , dipeptides
 .were from Sigma St. Louis, Mo, USA , and asolectin
w xwas cleaned up by the method of Sone et al. 16
beforehand. N-Hydroxysuccinamide activated
sepharose column with a spacer arm of six carbon
atoms between the N-hydroxysuccinimide group and
the matrix was purchased from Pharmacia HiTrap
.NHS-activated 5 ml, Uppsala, Sweden . N-Glycanase
 4 .peptide-N N-acetyl-b-glucosaminyl asparagine
.amidase; EC 3.5.1.52 was obtained from Genzyme
 .Cambridge, MA . The enzyme was dialyzed against
0.2 M sodium phosphate buffer, pH 8.6, prior to use
w14 xto remove glycerol. C Glycylsarcosine
 y1.4.07 GBq mmol was purchased from Moravek
 .Biochemcals Brea, CA, USA . All other chemicals
were of reagent grade.
2.2. Solubilization of brush-border membrane pro-
teins
 .The brush-border membrane BBM fraction was
isolated from the small jejunum of the male Wistar
rat by the divalent cation precipitation method of
w xKessler et al. 17 with several modifications as in our
w xprevious paper 14 . The final pellet was resuspended
in a buffer composed of 100 mM mannitol, 100 mM
 .KCl, and 20 mM Hepes-Tris pH 7.5 . The protein
concentration was adjusted to 20 mgrml, and the
suspension stored at y808C until use.
BBM proteins were solubilized with 50 mM n-oc-
tylglucoside at a protein concentration of 10 mgrml
 .in the presence of 1 mM DTT dithiothrietol , 50 mM
 .PMSF phenylmethylsulfonyl fluoride 10% glycerol,
3 mM EDTA, 100 mM KCl and 20 mM Hepes-Tris
 .pH 7.5 . After centrifuging at 100 000 =g for
45 min, the clear supernatant was used for liposomal
reconstitution and further purification.
2.3. Application onto the ceftibuten-affinity column
As illustrated in Fig. 1, ceftibuten was coupled to
the NHS-activated gel according to the method de-
w xscribed our previous study 12 . Transport activity
was purified by applying the solubilized BBM pro-
teins onto the ceftibuten-affinity column equilibrated
with a starting buffer containing 50 mM NaCl, 1 mM
EDTA, 0.3 mM DTT, 5 mM lactic acid, 6.8 mM n-
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 .octylglucoside and 20 mM Mes-Tris pH 6.0 as de-
w xscribed in our previous report 12 . Following the
decrease of the absorbance at 280 nm of the eluate to
the basic level, the weakly bound proteins eluted
from the affinity column by a 0.5 M NaCl in the
starting buffer. Then the highly bound proteins were
eluted at 3.5 M NaCl. The fractions corresponding to
the eluted peaks were collected in ice-cold tubes and
processed for reconstitution, SDSrPAGE, and pro-
tein estimation.
2.4. Reconstitution into proteoliposomes
Each protein fraction from either the initial lysate
or the affinity chromatography eluates was mixed
with an asolectin micellar solution in 50 mM n-octyl-
 .glucoside protein : lipids1 : 20 wrw , and the mix-
ture was dialyzed against 20 mM Hepes-Tris buffer
 .pH 7.5 containing 0.1 mM EDTA, 2.5 mM MgCl2
and 0.1 mM DTT for 36 h at 48C. The proteo-
liposomes were harvested by centrifugation at
100 000=g for 1 h. The resulted pellet of proteo-
liposomes was resuspended in a minimal volume of
the experimental buffer for uptake measurement.
2.5. Uptake experiments
w14 xThe uptake of ceftibuten or C glycylsarcosine
into the prepared proteoliposomes was performed at
308C by the rapid filtration method as described
w xpreviously 11,12 . The reaction was initiated by the
mixing with an uptake buffer 100 mM mannitol,
.100 mM KCl, 20 mM Mes-Tris, pH 5.5 containing
substrates. After the stated time, the reaction was
stopped by diluting the mixture with 4 ml of an
ice-cold stop solution containing 150 mM NaCl and
20 mM Hepes-Tris, pH 7.5. The contents of the tube
were immediately filtered under vacuum through a
 .Millipore filter HAWP, 0.45 mm, 2.5 cm diameter .
The filter was then washed once with 4 mL of the
ice-cold stop buffer. Substrates trapped on the filter
were extracted with 300 ml of the stop buffer.
2.6. Analytical procedures
The detection of ceftibuten was carried out by the
w xuse of HPLC as described previously 12 . The con-
w14 xcentration of C glycylsarcosine was determined by
liquid scintillation counting. Protein was measured by
w xthe method of Lowry et al. 18 with bovine serum
albumin as the standard. Lipid phosphorus was mea-
w xsured by the ashing technique of Bartlett 19 .
2.7. SDS-polyacrylamide gel electrophoresis
SDSrPAGE analysis was performed using a com-
mercially available minislab gel MULTI GEL type-
  .  . .  .10 84 W =90 H =1 mm , 10% wrv acrylamide
 . X .and 0.3% wrv N, N -methylenebisacrylamide
 .Fig. 1. Immobilization of ceftibuten to an activated N-hydroxysuccinimide NHS activated sepharose matrix.
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 .Fig. 2. Uptake profile of ceftibuten 1.0 mM by proteoliposomes
prepared from reconstituting the total protein extract of the
intestinal brush-border membranes into asolectin lipid vesicles by
dialysis method. Uptake was measured in the presence, or ab-
q  .  .  .sence of an inward H gradient ‘ – pH 7.5 r pH 5.5 ;in out
 . . v – pH spH s5.5 . Each value is the mean"SEM nsin out
.4 .
Fig. 3. Effect of Compound V and dipeptides on the initial
 .  .0.5 min uptake of ceftibuten 1.0 mM by the proteoliposomes
prepared from reconstituting the total protein extract of the
intestinal brush-border membranes into asolectin lipid vesicles by
dialysis method. Uptake was measured in the presence of an
q  .inward H gradient pH 7.5, pH 5.5 . Each value representsin out
 . )))the mean"SEM ns4 . P -0.001, Significantly different
from control.
Fig. 4. Hq-gradient-dependent glycylsarcosine uptake by the
proteoliposomes prepared from reconstituting the total protein
extract of the intestinal brush-border membranes into asolectin
lipid vesicles by dialysis method. Uptake was measured in the
q  . presence, or absence of an inward H gradient ‘ – pHin
.  .  . .7.5 r pH 5.5 ; v – pH spH s5.5 . Each value is theout in out
 . )mean"SEM ns6 . P -0.05; Significantly different from
control, )) P -0.01.
Fig. 5. Affinity chromatography of the n-octylglucoside extract
of rat intestinal brush-border membrane for the purification of
ceftibuten transport activity. Solubilized proteins n-octyl-
.glucoside extract were fractionated on a ceftibuten-immobilized
affinity column as described under Section 2. Uptake activities of
 .ceftibuten 1.0 mM were determined using proteoliposomes pre-
pared from the void volume, the 0.5 and 3.5 M NaCl-eluted
fractions.
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equipped with a Model DPE-220C vertical elec-
 .trophoresis apparatus Daiichi, Tokyo, Japan and the
w xLaemmli 20 buffer system. Prior to SDSrPAGE,
the proteins from the different fractions were precipi-
w xtated by the method of Wessel and Flugge 21 as¨
w xmodified by Kramer et al. 22 . The dried protein
precipitates were dissolved in 40–50 ml of a loading
 .buffer containing 62.5 mM Tris-HCl pH 6.8 , 2%
SDS, 5% 2-mercaptoethanol, 10% glycerol and
0.001% bromophenol blue. The mixture was vigor-
ously vortexed for 2 min and then incubated for 5 min
in a boiling water. Resolving the proteins at 40 mA
 .using the electrode buffer pH 8.4 containing 25 mM
Tris, 192 mM glycine and 10% SDS, the gel was
visualized with Coomassie brilliant blue staining.
Molecular-mass determinations ware made by using a
 .Sigma calibration unit SDS-6H, Sigma . Deglycosy-
lation of 3.5 M-NaCl eluted fraction by N-glycanase
w xwas according to the method of Hirai et al. 23 as
described in the legend of Fig. 8.
3. Results
3.1. Solubilization and liposomal reconstitution of the
H qrceftibuten co-transport acti˝ity
w xOur previous report 11 showed that an n-octyl-
glucoside concentration of 50–60 mM is optimal for
extracting the uptake activity of ceftibuten from the
renal BBM. In the present study, proteoliposomes
prepared from the total extract of the small intestinal
BBM by dialysis had an initial uptake rate of 7.5 nmol
ceftibutenrmg protein per min with an overshooting
a c c u m u la tio n o f 8 0 2 .0 2 " 1 9 .9 4 p m o l
ceftibutenrmmol phosphorus 15.0 nmolrmg pro-
.tein at 2 min-incubation. These values are approxi-
mately three- and fourfold, respectively, greater than
those obtained in the absence of an inward Hq
 .gradient Fig. 2 .
Fig. 3 shows that compound V, a ceftibuten ana-
log, and dipeptides significantly inhibited the uptake
 .Fig. 6. Uptake of ceftibuten 1.0 mM by proteoliposomes prepared from the void volume, the 0.5 or 3.5 M NaCl-eluted fraction of
q  .affinity chromatography. Uptake experiments were performed in the presence of an inward H gradient pH s7.5, pH s5.5 within out
 .  .  .  . )))hatched column rwithout opened column L-valyl-L-proline 10 mM . Each value represents the mean with SEM ns4 .
 .P-0.001, Significantly different from control opened column .
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of ceftibuten into the proteoliposomes of the total
membrane extract. Furthermore, the values of equi-
librium uptake at 30-minute incubations were almost
the same in the presence, or absence of inhibitors,
indicating that the presence of inhibitors did not
w3 xaffect the vesicle size. Additionally, H -glycyl-
sarcosine uptake into these proteoliposomes exhibited
a distinct stimulation by an inwardly directed Hq
 .gradient Fig. 4 which was similar to that observed
 .in the original BBM vesicles data not shown . The
present results give an evidence that the transport
activities of dipeptides in the proteoliposomes of the
total BBM extract are similar to those described in
w xthe original brush-border membrane vesicles 24 .
3.2. Ceftibuten-immobilized affinity chromatography
of the intestinal BBM proteins
Fig. 5 illustrates the elution profile after applying
the solubilized BBM proteins on the affinity column.
w xAs in the case of renal preparation 12 , the liposomal
reconstitution of the void volume and the 0.5 M
NaCl-eluted fractions revealed that these fractions do
not seem to have a specific uptake activity for
ceftibuten, whereas the proteoliposomes reconstituted
from the 3.5 M NaCl-eluted fraction showed a high
uptake activity which was completely inhibited by
 .the dipeptide, L-valyl-L-proline Fig. 6 . The equilib-
rium uptake values into all the three kinds of proteo-
liposomes were almost similar, indicating that the
vesicles in these liposomal preparations are of similar
size.
3.3. SDSrPAGE of the membrane protein fractions
obtained from ceftibuten-immobilized affinity chro-
matography
Analyzing each purification step by SDSrPAGE
revealed the presence of two polypeptides with ap-
parent molecular masses of 127"5 and 117"5 in
 .the 3.5 M NaCl-eluted fraction Fig. 7 . These poly-
peptides were not found in the 0.5 M NaCl-eluted
fractions. Due to the fact that the SDSrPAGE analy-
sis of the 40 mM ceftibuten-eluted fraction also
showed a similar result to the 3.5 M NaCl-eluted
 .fraction data not shown , the highly bound proteins
eluted by 3.5 M NaCl seems to be specific for
Fig. 7. SDSrPAGE analysis of the eluted fractions of affinity chromatography. BBM, crude extract of brush-border membrane proteins;
0.5 M-NaCl, 0.5 M NaCl-eluted fraction; 3.5 M-NaCl, 3.5 M NaCl-eluted fraction of ceftibuten-immobilized affinity chromatography.
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Fig. 8. Effect of deglycosylation by N-glycanase on the band-shift
of 3.5 M-eluted fraction on SDSrPAGE analysis. After dialysis
of 3.5 M NaCl-eluted fraction against 50 mM phosphate buffer
 .pH 8.6 containing 0.5% SDS and 50 mM b-mercaptoethanol,
 .5ml of 7.5% Nonidet p-40 NP-40 and 0.3 U of N-glycanase
were added to 10 ml of protein sample aliquot, and the sufficient
distilled water to a final volume of 30 ml was added. The mixture
was incubated for 18 h at 378C. The reaction was stopped by
boiling for 5 min.
ceftibuten, but not due to a non-specific adsorption.
These 127 and 117 kDa protein bands shifted back to
120 and 78 kDa products, respectively, after digestion
 .with N-glycanase EC 3.5.1.52 as shown in Fig. 8.
4. Discussion
w xOur previous reports 11,12 showed that the dialy-
sis method for the liposomal reconstitution of the
Hqrpeptide transport activity in the renal BBM is
more reliable than the freezerthaw technique. Simi-
larly, in the present study, we found that proteo-
liposomes derived from the intestinal BBM by the
dialysis method are more reliable than the
freezerthaw technique with regard to the Hq-depend-
ency of ceftibuten uptake. It seems that the slow
removal of detergent by dialysis permits a safe and
proper reconstitution of the transport activity of
ceftibuten with characteristics similar to those de-
scribed in the original brush-border membrane vesi-
w xcles of rat intestine 24 .
w xIn a previous paper 25 , we have observed by
kinetic analysis that ceftibuten transport is mediated
 .by two transport systems high- and low-affinity in
the renal brush-border membrane and by one trans-
port system in the intestinal brush-border membrane.
However in the present study, SDSrPAGE analysis
revealed that two intestinal proteins can interact
strongly with ceftibuten as a ligand in affinity chro-
matography. The apparent molecular masses of these
proteins shifted from 117 and 127 kDa to 78 and
120 kDa, respectively, by N-glycanase digestion. The
rat PepT1 cDNA consists of 2921 bp with an open
reading frame encoding a 710 amino acid protein
with a calclated molecular mass of 79 kDa, although
the molecular size of the PepT1 transport protein core
w xis reported to be ;63 kDa 8 . It was shown that a
protein with an apparent molecular mass of 75 kDa is
detectable in rat intestinal brush-border membrane by
immunoblotting with polyclonal antibodies, raised
w xagainst the carboxyl termini of rat PepT1 8 . In
w xcontrast, Kramer et al. 26,27 observed by photo-
affinity labeling that a 127 kDa polypeptide is a
component of the intestinal oligopeptide transport
system. Our present results demonstrate that a protein
with a molecular size of 127 kDa as well as another
protein of 117 kDa protein core molecular size:
.78 kDa recognize the structure of ceftibuten immobi-
Table 1
Purification levels of the Hq-dependent ceftibuten transport activ-
ity from rat intestinal brush-border membrane a
Step Specific activity Purification Yield
 .  .  .pmolrmg proteinrs -fold %
Brush-broader 26.1 1.0 100.0
membrane
n-Octylglucoside 123.1 4.7 56.3
extract
Affinity 10 651.5 615.0 0.26
chromatography
a An aliquot at each step was reconstituted into proteoliposomes
and the activity of ceftibuten transport in the presence of an
inward Hq gradient was determined. Final concentration of
ceftibuten in the incubation medium was 1.0 mM. Each data point
was expressed by means of three or four measurements.
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lized to sepharose beads. It is unlikely that the 3.5 M
NaCl-eluted fraction contains any protein related to
the intestinal anion transport system because that
lactic acid, a typical substrate for the anion trans-
porter, was included in the starting buffer along the
affinity chromatography course.
It follows from the foregoing discussion that there
are two possibilities for explaining the contradiction
of the kinetic observations with those of purification.
The first is the supposition that two transport systems
are present in the intestine but with very close sub-
strate affinities, which makes the kinetic approach
inefficient in distinguishing them. The other possibil-
ity is that the intestinal transporter is a heterodimer
composed of two subunits, one is the PepT1 the
. catalytic subunit , and the other the regulatory sub-
.unit is the 127 kDa protein isolated by Kramer et al.
w x26,27 . Finding which of the two possibilities is
factual needs further investigation, but we think that
our affinity chromatography approach of this study
provides a valuable tool for answering the many-sided
questions on oligopeptide transport mechanism.
It is noteworthy that the purification protocol pre-
sented in this study allowed a 615-fold purification
compared with the crude brush-border membrane
 .fraction Table 1 .
Amino acid sequencing and sugar analysis of the
isolated protein are in progress.
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